Diseases, Conditions, Syndromes

Beta-blocker trial does not reduce risks for COPD patients

New research from scientists at the University of Alabama at Birmingham published in the New England Journal of Medicine has found that beta-blockers used in a clinical trial for patients with chronic obstructive pulmonary ...

Health

Environmental health risks of livestock farming

Emissions from livestock farms cause asthma and COPD patients living nearby to experience more exacerbations, according to research presented today at the European Respiratory Society's Annual Congress in Amsterdam.

Diseases, Conditions, Syndromes

Study evaluates parents' reluctance to vaccinate asthmatic kids

Concern over vaccine safety is one of the primary factors preventing parents from having their asthmatic children vaccinated for influenza, or flu, according to Michigan researchers. Parents who do not vaccinate their children ...

Diseases, Conditions, Syndromes

ATS: Indacaterol-glycopyrronium cuts COPD exacerbations

(HealthDay)—For patients with a history of chronic obstructive pulmonary disease (COPD) exacerbations, indacaterol-glycopyrronium is more effective for prevention of exacerbations than salmeterol-fluticasone, according ...

Diseases, Conditions, Syndromes

Physical activity found to decrease risk of dying in COPD

Any amount of moderate to vigorous physical activity can effectively reduce the risk of dying after hospitalisation for chronic obstructive pulmonary disease (COPD), according to a new study.

Diseases, Conditions, Syndromes

Increased risk of MI, ischemic stroke after COPD exacerbation

(HealthDay)—For adults with chronic obstructive pulmonary disease (COPD), acute exacerbations are associated with increased risk of myocardial infarction and ischemic stroke, according to a study published online May 3 ...

Diseases, Conditions, Syndromes

Small reduction in lung function with Tx de-escalation in COPD

(HealthDay)—A de-escalation from triple therapy to indacaterol/glycopyrronium may lead to a small reduction in lung function in non-frequently exacerbating patients with chronic obstructive pulmonary disease (COPD) but ...

page 5 from 14